Please ensure Javascript is enabled for purposes of website accessibility

ArQule(ARQL)

NASDAQ

ARQL
ArQule Stock Quote

A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics.

Interactive Chart


News & Analysis: ArQule

All

Market Moves

Earnings










ArQule: Buy the Dip?

The pharma company has wowed investors with solid clinical data multiple times this year.